Tag: insilico_medicine
-
Media Monitor: AI-Generated Inventions Face Patent Hurdles in U.S. Law
MIT Technology Review reports that despite AI's role in drug discovery, U.S. patent law currently only recognizes humans as inventors, creating intellectual property challenges for companies like Insilico Medicine.
BusinessScience & TechnologyPolitics and GovernmentLegalArtificial IntelligenceMedical ScienceFederal GovernmentEconomyGeneral Politics AIPatentsIntellectual PropertyDrug DiscoveryInsilico MedicineRyan AbbottUS LawMIT Technology ReviewMITsciencetechnology